Preview

Health and Ecology Issues

Advanced search

Comparative Analysis of Methylation of Genes Associated with Breast Cancer and Prostate Cancer, and the Diagnostic Potential of the Method on its Basis

https://doi.org/10.51523/2708-6011.2018-15-4-20

Abstract

Objective: to compare the methylation rates of nine genes in prostate cancer and breast cancer and to identify a single panel of genes that is promising for its use as an additional marker in the diagnosis of these types of cancer. Material and methods. The methylation analysis of promoter areas of 9 genes ( RARβ , HIN1 , DAPK , RASSF1A , GSTP1 , CCND2 , p16 , APC and hMLH1 ) was performed by means of methylspecific polymerase chain reaction with electrophoretic detection. Results. We have identified and compared the methylation rates of the 9 genes in the biopsy material of 68 patients with prostate cancer, 39 patients with benign prostatic hyperplasia / prostatic intraepithelial neoplasia (BPH/PIN), surgical material from 104 female patients with breast cancer and 38 patients with benign tumors of the mammary gland (fibroadenoma, nodal mastopathy). Conclusion. It has been found that methylation of five genes ( RARβ , HIN1 , CCND2 , APC and GSTP1 ) out of the nine analyzed genes is statistically significantly more common in samples of malignant tumor tissue compared to that in samples with benign pathology both among patients with prostate diseases and among patients with breast pathology. The methylation rate of each of these five genes is significantly higher in the tumor tissue of patients with prostate cancer compared to those with breast cancer. Methylation of two or more genes out of five in prostate cancer was detected in 89.7 % of cases, in BPH / PIN - in 23.1 %, which is 3.9 times as little, OR - 29.1 (95 % CI [9.9-85, 6]), p < 0.001. The diagnostic sensitivity of the method was 89.7 % with specificity of 76.9 % and accuracy of 85.0 %. Methylation of one or more genes out of five in the group of patients with breast cancer was detected in 80.8 % cases, with benign tumors of the mammary gland in 13.2 % cases, which is 6.1 times as little, OR - 27.7 (95 % CI [9.6-80.0]), p < 0.001. Accordingly, the sensitivity of the method was equal to 80.8 %, specificity - 86.8 %, and accuracy - 82.4 %.

About the Author

V. N. Martinkov
State institution "Republican Scientific and Practical Center Radiation Medicine and Human Ecology "
Belarus


References

1. Delpu Y, Cordelier P, Cho WC, Torrisani J. DNA methylation and cancer diagnosis. Int J Mol Sci. 2013;14(7):15029-58. doi: 10.3390/ijms140715029.

2. Perry AS, Foley R, Woodson K, Lawler M. The emerging roles of DNA methylation in the clinical management of prostate cancer. Endocr Relat Cancer. 2006;13(2):357-77. doi: 10.1677/erc.1.01184.

3. Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, et al. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci. Clin Cancer Res. 2005;11(11):4097-106. doi: 10.1158/1078-0432.CCR-04-1832.

4. Long MD, Smiraglia DJ, Campbell MJ. The genomic impact of DNA CpG methylation on gene expression; relationships in prostate cancer. Biomolecules. 2017 Feb 14;7(1):1-20. doi: 10.3390/biom7010015.

5. Jovanovic J, Rønneberg JA, Tost J, Kristensen V. The epigenetics of breast cancer. Mol Oncol. 2010;4(3):242-54. doi: 10.1016/j.molonc.2010.04.002.

6. Xu J, Shetty PB, Feng W, Chenault C, Bast RC, Issa J-PJ, et al. Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome. BMC Cancer. 2012;12:243. doi: 10.1186/1471-2407-12-243.

7. Hoque MO, Feng Q, Toure P, Dem A, Critchlow CW, Hawes SE, et al. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J Clin Oncol. 2006;24(26):4262-69. doi: 10.1200/JCO.2005.01.3516.

8. Rouprêt M, Hupertan V, Yates DR, Catto JWF, Rehman I, Meuth M, et al. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage. Clin Cancer Res. 2007;13(6):1720-25. doi: 10.1158/1078-0432.CCR-06-2467.

9. Van Neste L, Partin AW, Stewart GD, Epstein JI, Harrison DJ, Van Criekinge W. Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies. Prostate. 2016;76(12):1078-87. doi: 10.1002/pros.23191.

10. Zhao F, Olkhov-Mitsel E, van der Kwast T, Sykes J, Zdravic D, Venkateswaran V, et al. Urinary DNA methylation biomarkers for non-invasive prediction of aggressive disease in patients with prostate cancer on Active Surveillance. J Urol. 2017;197(2):335-41. doi: 10.1016/j.juro.2016.08.081.

11. Hoque MO, Feng Q, Toure P, Dem A, Critchlow CW, Hawes SE, et al. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J Clin Oncol. 2006;24(26):4262-69. doi: 10.1200/JCO.2005.01.3516.

12. Tao MH, Shields PG, Nie J, Millen A, Ambrosone CB, Edge SB, et al. DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat. 2009;114(3):559-68. doi: 10.1007/s10549-008-0028-z.

13. Strand SH, Orntoft TF, Sorensen KD. Prognostic DNA methylation markers for prostate cancer. Int J Mol Sci. 2014;15(9):16544-76. doi: 10.3390/ijms150916544.

14. Силин АЕ, Мартинков ВН, Надыров ЭА, Пестриков ЕВ, Либуркин ОМ, Задорожнюк АА, и др. Сравнительный анализ статуса метилирования 11 генов-супрессоров в ткани предстательной железы пациентов с доброкачественной патологией, раком предстательной железы и лиц без патологии. Проблемы Здоровья и Экологии. 2012;4:92-8.

15. Силин АЕ, Мартинков ВН, Надыров ЭА, Мартыненко СМ, Родько ДБ. Частоты гиперметилирования промоторных областей генов-супрессоров при раке молочной железы. Мед-Биол Проблемы Жизнедеятельности. 2010;1:56-63.


Review

For citations:


Martinkov V.N. Comparative Analysis of Methylation of Genes Associated with Breast Cancer and Prostate Cancer, and the Diagnostic Potential of the Method on its Basis. Health and Ecology Issues. 2018;(4):103-109. (In Russ.) https://doi.org/10.51523/2708-6011.2018-15-4-20

Views: 289


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2220-0967 (Print)
ISSN 2708-6011 (Online)